We observed a significant increase of surface HER-3 expression in the advanced metastatic primary CRC compared to early-stage tumors both in terms of percentage of positive specimens and mean positive tumor cells in tissues (76,8 versus 100% of positive tissues; 25,7% versus 76,1% of mean positive tumor cells). The gene discussed is ERBB3; the disease is neoplasm.